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Replication and pathogenesis of the human immunodeficiency virus (HIV) is tightly linked to the structure of its RNA
genome, but genome structure in infectious virions is poorly understood. We invent high-throughput SHAPE (selective
29-hydroxyl acylation analyzed by primer extension) technology, which uses many of the same tools as DNA
sequencing, to quantify RNA backbone flexibility at single-nucleotide resolution and from which robust structural
information can be immediately derived. We analyze the structure of HIV-1 genomic RNA in four biologically
instructive states, including the authentic viral genome inside native particles. Remarkably, given the large number of
plausible local structures, the first 10% of the HIV-1 genome exists in a single, predominant conformation in all four
states. We also discover that noncoding regions functioning in a regulatory role have significantly lower (p-value
, 0.0001) SHAPE reactivities, and hence more structure, than do viral coding regions that function as the template for
protein synthesis. By directly monitoring protein binding inside virions, we identify the RNA recognition motif for the
viral nucleocapsid protein. Seven structurally homologous binding sites occur in a well-defined domain in the genome,
consistent with a role in directing specific packaging of genomic RNA into nascent virions. In addition, we identify two
distinct motifs that are targets for the duplex destabilizing activity of this same protein. The nucleocapsid protein
destabilizes local HIV-1 RNA structure in ways likely to facilitate initial movement both of the retroviral reverse
transcriptase from its tRNA primer and of the ribosome in coding regions. Each of the three nucleocapsid interaction
motifs falls in a specific genome domain, indicating that local protein interactions can be organized by the long-range
architecture of an RNA. High-throughput SHAPE reveals a comprehensive view of HIV-1 RNA genome structure, and
further application of this technology will make possible newly informative analysis of any RNA in a cellular
transcriptome.
Citation: Wilkinson KA, Gorelick RJ, Vasa SM, Guex N, Rein A, et al. (2008) High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across
distinct biological states. PLoS Biol 6(4): e96. doi:10.1371/journal.pbio.0060096
Introduction
As is the case with many natural RNAs, the function of the
HIV RNA genome is strongly linked to its ability to form
higher-order structure and to interact with protein effectors
in each stage of its replication cycle. The 59 end of the HIV
genome alone contains a noncoding, highly structured region
that is involved in viral packaging, dimerization, pairing with
the cellular tRNA primer for cDNA synthesis, and binding
numerous viral proteins [1,2].
Immediately downstream of this regulatory region, the HIV
genome contains nine open reading frames. The ﬁrst protein
encoded by the HIV-1 genome is Gag, which is ultimately
cleaved into a complex set of proteins, including matrix,
capsid, and nucleocapsid [2]. The nucleocapsid protein has
two dissimilar RNA binding activities. First, as part of the Gag
precursor protein, the nucleocapsid domain speciﬁcally
recognizes and directs the HIV genome to be packaged into
new virions [3–5] in the context of a vast excess of other
cellular RNAs. In contrast, the nucleocapsid protein also has a
signiﬁcant duplex destabilizing activity, which plays a key role
in facilitating the RNA annealing and rearrangement events
essential for viral reverse transcription [6,7].
Because of its importance in regulating replication and for
governing interactions with protein cofactors, extensive
efforts have been directed towards developing structural
models for the HIV-1 genome and for identifying candidate
interaction sites for the nucleocapsid protein. Multiple
models based on phylogenetic, chemical mapping, and
mutagenesis approaches have been proposed [8–17]. In
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PLoS BIOLOGYgeneral, agreement between proposed structures is limited to
highly structured hairpins; large zones of disagreement
between models are common. The available experimental
and sequence information is not sufﬁcient to support one
model over another. This lack of consensus in understanding
HIV genome structure reﬂects challenges common to the
analysis of any large RNA in its native biological context.
One of the most successful methods for determining an
RNA secondary structure has been phylogenetic covariation
analysis [18,19]. However, this method has a narrow range of
usefulness in that homologous RNAs must be similar enough
to form the same structure, but simultaneously exhibit
sufﬁcient polymorphism to be informative. Few RNAs meet
this standard. In the case of HIV and most viral RNAs,
sequences are typically too similar to each other to provide
sufﬁcient constraints over large regions.
Alternatively, RNA structural information can be inferred
by treatment with chemicals or enzymes that discriminate
between paired and unpaired nucleotides [20,21]. This
reactivity information is then used to choose among various
models, usually predicted with the assistance of thermody-
namic folding algorithms. Conventional chemical and enzy-
matic mapping information has a narrow dynamic range and
is usually available only for 25% to 50% of nucleotides in an
RNA. As a result, conventional mapping experiments tend to
focus on short pieces of RNA in artiﬁcial contexts and rely
heavily on thermodynamic prediction and extrapolation to
relate structures and protein binding sites identiﬁed in vitro
to the biology of large RNAs in their native contexts. When
used against intact viral particles, conventional probes have
thus far also been unable to detect protein–RNA interactions
inside HIV virions [16].
Therefore, comprehensive and accurate analysis of any
cellular or viral RNA in a relevant biological context requires
a new technology that may be used for any RNA sequence
under a wide variety of biologically relevant conditions. Our
approach is based on the observation that electrophiles, such
as N-methylisatoic anhydride (NMIA), react selectively with
ﬂexible RNA nucleotides at the ribose 29-hydroxyl group
(Figure 1) [22].
The RNA is exposed to NMIA at a concentration that yields
approximately one 29-O-adduct per 300 nucleotides (nts).
Adducts are detected by their ability to inhibit primer
extension by reverse transcriptase. A control extension
reaction omitting NMIA to assess background, along with
dideoxy sequencing extensions to assign nucleotide positions,
are performed in parallel. These combined steps are called
selective 29-hydroxyl acylation analyzed by primer extension,
or SHAPE [22–24]. Because the four canonical RNA nucleo-
tides each contain a 29-hydroxyl group, local nucleotide
ﬂexibility at all sites in an RNA is quantitatively interrogated
in a single experiment.
In this work, we couple SHAPE chemistry with automated
data readout and analysis systems so that hundreds of
nucleotides of RNA structure can be analyzed in a single
experiment. The overarching impact of this technology begins
to realize the goal of making RNA structure analysis roughly as
simple as contemporary DNA sequencing. High-throughput
SHAPE (hSHAPE) makes it possible to rapidly measure RNA
backbone ﬂexibility at greater than 90% of the nucleotides in
an RNA under a variety of biologically relevant conditions.
To demonstrate the power of hSHAPE while examining
one of the most functionally important regions of an HIV
genome, we applied hSHAPE to the ﬁrst 900 nts of the 59 end
of the HIV-1 genome, under four biologically informative
states. The data from these experiments allow us to address a
comprehensive set of challenges that all require accurate
knowledge of the structure of the HIV RNA genome: Does the
viral genome have a global, long-range architecture, or is it
largely organized as a series of isolated structural elements? Is
it possible to identify RNA regulatory motifs based on their
underlying RNA structure? Can consensus RNA binding sites
be identiﬁed for the viral nucleocapsid protein, and if so, are
these organized in domains? Can nucleocapsid interaction
sites that function in speciﬁc RNA binding and genome
packaging be distinguished from those that are targets for
duplex destabilization by this same protein? If two classes of
interaction sites for the nucleocapsid protein can be
identiﬁed, do the speciﬁc binding and duplex destabilization
activities operate in the same or in neighboring regions of the
HIV genome?
Results
hSHAPE Strategy
To create the technology necessary to analyze long regions
of an RNA in biologically relevant environments in a single
experiment, we performed each extension using a primer
labeled with a color-coded ﬂuorophore. The resulting cDNA
products (from the (þ) and ( ) reagent reactions plus two
Figure 1. Scheme for RNA SHAPE Chemistry
doi:10.1371/journal.pbio.0060096.g001
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Structures of the HIV-1 Genome
Author Summary
The function of the RNA genome of the human immunodeficiency
virus (HIV) is determined both by its sequence and by its ability to
fold back on itself to form specific higher-order structures. In order
to describe physical structures in a region of the HIV RNA genome
known to play multiple, critical roles in viral replication and
pathogenesis, we invent a high-throughput, quantitative, and
comprehensive structure-mapping approach that locates flexible
(unpaired) nucleotides within a folded RNA, assaying hundreds of
nucleotides at a time. We find that the first 10% of the HIV-1
genome has a single predominant structure and that regulatory
motifs have significantly greater structure than do protein-coding
segments. The HIV genome interacts with numerous proteins,
including multiple copies of the nucleocapsid protein. We directly
map RNA–protein interactions inside virions and discover that the
nucleocapsid protein +interacts with viral RNA in at least three
distinct ways, depending on the context within the overall genome
structure. Further application of the high-throughput RNA-structure
analysis tools described here will make it possible to address diverse
structure–function relationships in intact cellular and viral RNAs.sequencing traces) are combined and resolved in one multi-
ﬂuor run by automated capillary electrophoresis. In a single
multiplex hSHAPE read, we typically obtain 250–400 nts of
quantitative RNA structural information at single-nucleotide
resolution (Figure 2A).
These elution time versus dye amount data resemble DNA
sequencing information analyzed by capillary electrophore-
sis, and require similar preprocessing steps, such as baseline
correction and corrections for ﬂuorescent multiplexing [25].
However, whereas DNA sequencing requires detection of
only the most intense peak at each position, the amplitudes in
the (þ) and ( ) NMIA reagent channels in an hSHAPE
experiment report quantitative RNA structural information.
Peaks with little or no reactivity in the (þ) NMIA channel
correspond to RNA nucleotides constrained by base pairing
or other interactions, whereas tall peaks indicate conforma-
tionally ﬂexible positions (red and blue traces, Figure 2A).
The dynamic range that distinguishes ﬂexible from paired
nucleotides is approximately 30-fold.
We calculated quantitative SHAPE reactivity information
at every nucleotide position by developing hSHAPE-speciﬁc
processing algorithms that (1) align the (þ) and ( ) NMIA
channels to the RNA sequence (Figure 2A), (2) integrate the
(þ) and ( ) NMIA peaks (Figure 2B), (3) correct signal decay
(black line, Figure 2C), and (4) normalize SHAPE reactivities
to a universal scale (Figure 2D). In this case, these steps
produce a single-nucleotide resolution view of RNA ﬂexibility
for HIV-1 nucleotides 8 through 286 (Figure 2D).
To verify the accuracy of hSHAPE, we superimposed
SHAPE reactivities on the well-characterized TAR and
poly(A) stem-loops (nucleotides 1–104), which is the only
region in the ﬁrst 900 nts of the HIV RNA genome longer
than approximately 50 nts for which prior analyses have
converged on a single structural consensus [9,15,16]. The
SHAPE reactivity information is exactly consistent with the
consensus secondary structure model for this region (Figure
2E). Nucleotides with normalized SHAPE reactivities greater
than 0.5 are almost always single stranded (orange and red
columns, Figure 2E), whereas positions with reactivities less
than approximately 0.2 (purple bars, Figure 2E) are almost
always paired. Reactivities between these values (green) may
be paired or participate in other partially constraining
interactions. SHAPE reactivities also accurately report ﬁne-
scale structural differences. For example, nucleotides in the
UCU bulge in the TAR stem show intermediate reactivities
(Figure 2E), consistent with nuclear magnetic resonance
(NMR) studies [26] that indicate that these nucleotides are
partially stacked.
Structural Analysis of Four HIV-1 Genome States
Our goal was to determine the structure of and derive
biological inferences for the 59 region of the HIV-1 RNA
genome, as it exists inside wild-type viral particles. As will be
shown below, hSHAPE provides an extraordinarily detailed
and high-resolution view of the HIV-1 genome inside
authentic virions that reﬂects multiple biologically important
RNA–RNA and RNA–protein interactions. To identify and
characterize virion-speciﬁc RNA conformational changes and
RNA–protein interactions, we used hSHAPE to analyze the
structures of four states in total. In addition to (1) genomic
RNA inside virions (the in virio state), we compared the
structure of the in virio state with three simpler states
involving (2) authentic HIV-1 genomic RNA that had been
gently, but completely, deproteinized and extracted from
virions (ex virio), (3) genomic RNA inside virions, but in
which nucleocapsid-RNA interactions were selectively dis-
rupted in situ by treatment with Aldrithiol-2 (AT-2 treated,
described in detail below), and (4) a 976-nt HIV-1 transcript
generated in vitro in the absence of any viral component. We
used the protein-free ex virio RNA as the reference state for
comparison. This RNA state is strongly inﬂuenced by the
authentic virion environment but simultaneously lacks the
complex inﬂuence of bound proteins.
We constructed quantitative, single-nucleotide resolution
proﬁles for the ﬁrst 900 nts, or 10% of the HIV-1 genome, for
each of these four states by combining the information from
overlapping, and highly reproducible (Figure 3A) hSHAPE
reads. Two to three independent repetitions were obtained
for each primer; standard deviations are small, on the order
of 0.1 normalized SHAPE unit or less. By combining the
results of 32 individual hSHAPE experiments of approx-
imately 300 nts each, we obtained structural information for
94% of all nucleotides in these four states plus analysis of
three structural mutants, for a total analysis of 9,100 nts
(Figures 3B and S1).
Structural Model of the HIV-1 Genome
The nucleotide-resolution SHAPE reactivities for the large
analyzed region of the HIV-1 genome represent an unprece-
dented amount of structural information with which to
characterize RNA structure, protein binding sites, and
conformational changes that differentiate our four genome
states. However, comprehensive single-nucleotide resolution
data do not, by themselves, yield a secondary structure model
for an RNA.
We incorporate SHAPE reactivity information as an
additional quasi-energetic constraint into an existing ther-
modynamic model [27,28] for RNA secondary structure
prediction. Algorithms used to predict RNA structures from
sequence show large increases in accuracy when experimental
constraints are included in the prediction [28–30]. Ongoing
work from our laboratories shows that using SHAPE
information to constrain RNA secondary structure predic-
tion has a dramatic impact on the accuracy of predicted
structures. For example, prediction accuracy improves from
52% to 90% for the RNase P speciﬁcity domain [30] and from
38% to approximately 90% for the 1,542-nt Escherichia coli
16S rRNA (unpublished data). These predictions feature
overall topologies that closely resemble the correct structure,
with errors generally limited to local rearrangements at
multi-helix junctions.
SHAPE reactivities provide model-free information about
the extent of structure at each nucleotide. Therefore, in
addition to proposing a complete secondary structure for our
ex virio reference state (Figure 4A), we directly assessed the
well determinedness of each helix in the secondary structure
by increasing the relative weight of the SHAPE information
in calculating low free-energy structures. We term this
analysis the ‘‘pairing persistence’’ of each helix. Highly
persistent helices (black and purple bars indicating base
pairing in Figure 4A) form even when SHAPE reactivities
were used to impose large pairing penalties for even slightly
reactive nucleotides. Less persistent helices (blue and green
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Structures of the HIV-1 GenomeFigure 2. Analysis of HIV-1 RNA Genome Structure Using hSHAPE
(A) Intensity versus elution time for an hSHAPE analysis resolved by single capillary electrophoresis using the HIV-1 in vitro transcript. The (þ) and ( )
NMIA reactions (red and blue) are offset from the A and C sequencing lanes (black and green) for clarity.
(B) Whole-trace peak integration of a section of data from part (A). (þ) and ( ) peaks were fit to Gaussian curves (thin black lines) and aligned to the
sequencing channels.
(C) Signal decay correction for the (þ) NMIA trace assuming a constant probability for extension at each nucleotide (black line).
(D) Processed SHAPE reactivities as a function of nucleotide position. Highly reactive nucleotides (red and orange bars) report flexible positions in the
RNA.
(E) Absolute SHAPE reactivities superimposed on a secondary structure model for the TAR and Poly(A) stem-loops.
doi:10.1371/journal.pbio.0060096.g002
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Structures of the HIV-1 Genomebars, Figure 4A) form only when the SHAPE contributions to
the constraints are decreased.
The 59 Regulatory Domain Is More Highly Structured Than
Adjacent mRNA-Like Coding Sequences
The 59 end of the HIV genome contains two functional
regions whose boundary is the AUG start codon for the Gag
coding sequence (nucleotides 336–338; in bold, Figure 4A).
Positions 59 of the AUG start codon form a 340-nt–long
noncoding regulatory domain that plays multiple important
roles in the viral replication cycle. In contrast, nucleotides 39
of the start codon contain the Gag protein coding region, of
which we have analyzed approximately 560 nts.
An important unresolved issue has been whether regu-
latory motifs might be identiﬁed from single RNA sequences.
This is a challenging problem, and it is currently not possible
to distinguish coding versus noncoding regions by thermody-
namic secondary structure prediction alone [31,32]. hSHAPE
analysis directly addresses this issue in two ways.
First, the median SHAPE reactivity, a metric for the typical
amount of structure in the two regions, is 0.14 for the 59
regulatory domain and 0.40 for the 39 mRNA-like region
(dashed lines, Figure 4B). Differences in SHAPE reactivities
between the two regions are statistically signiﬁcant (Wilcoxon
rank sum test p-value , 0.0001) with both the median and
overall distribution being lower in the 59 regulatory domain
(Figure 4C). The inﬂection point in SHAPE reactivities is
nearly coincident with the AUG start codon (gray bar, Figure
4B). Second, the predicted secondary structure model can be
used to infer the density of stable base pairing interactions in
the 59 regulatory versus 39 coding regions. Nucleotides in the
59 regulatory domain are 1.7 times more likely to be paired
than those in the 39 coding region (Figure 4A). Although
there are some ﬂexible regions in the 59 regulatory domain
and a few stable duplexes in the 39 coding region, overall
there is a strong and statistically signiﬁcant difference in the
amount of structure in these two regions. Thus, by both
criteria, hSHAPE clearly distinguishes between regulatory
and coding regions within the HIV-1 genome because the
noncoding regulatory domain is more highly structured than
are coding sequences.
The HIV-1 Genome Forms a Single Predominant Structure
Comparison of the complete SHAPE reactivity proﬁles for
the ex virio reference state with three other very different
states—in virio, in virio with compromised nucleocapsid–
RNA interactions, and an in vitro transcript—unexpectedly
reveals that these four distinct states contain extensive
regions with essentially identical structures (Figure 3B). This
is a remarkable result, considering the different biochemical
histories of the four states. At the two extremes, the in virio
RNA was maintained in its native conformation inside virions
throughout the chemical interrogation step, whereas the in
vitro transcript RNA did not interact with any authentic viral
component, but instead, was synthesized and refolded
entirely in vitro.
Figure 3. Single Nucleotide Resolution hSHAPE RNA Structure Analysis Is Quantitative and Highly Reproducible
(A) SHAPE reactivities of two overlapping extension reactions for the in vitro transcript using primers that anneal approximately 200 nucleotides apart.
Solid and open bars indicate normalized SHAPE reactivities for primers that anneal at nucleotides 342–362 and 535–555, respectively. Error bars
represent standard deviations calculated from independent experiments using the same primer.
(B) Complete SHAPE data for HIV-1 genomic RNA analyzed in virions and in the ex virio, AT-2–treated, and in vitro transcript states (see Dataset S1).
doi:10.1371/journal.pbio.0060096.g003
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Structures of the HIV-1 GenomeWe performed several control experiments to test how well
hSHAPE detects signiﬁcant, but local, differences in RNA
conformation. These experiments encompassed analyzing an
in vitro transcript containing a deletion of the U
22CU
24 bulge
in TAR, comparing the 976-nt in vitro transcript with a 39
deletion that disrupts the pseudoknot at positions 79–85/443–
449, and dissociating tRNA(lys3) from the ex virio RNA by a
heating step. In each case, we detected strong changes in
SHAPE reactivity exactly in the region whose structure was
disrupted (see Figure S1). These experiments are consistent
with prior work that demonstrates that SHAPE is exquisitely
sensitive to small changes in local RNA structure
[23,29,30,33–36] and indicates that if structural differences
exist between any two of our HIV-1 states, they are detectable
by hSHAPE.
In all normal retroviral particles, the genomic RNA exists
as a dimer, with similar or identical RNA strands linked
together by a limited number of base pairs and tertiary
interactions. The dimeric structure appears to be a critical
element in the selective packaging of the genome [37,38] and
Figure 4. Architecture and Protein Modulation of the Structure of the HIV-1 NL4–3 RNA Genome
(A) Secondary structure model generated by SHAPE-constrained folding of the ex virio state. All four states fold to this structure. Nucleotides proposed
to form intermolecular base pairs with a second monomer are enclosed within a black box; the AUG start codon for the Gag polyprotein (nucleotide
336) is boldface. Nucleotides are colored according to their SHAPE reactivity; bars indicating base pairing are colored by their pairing persistence. Effects
of pretreatment of viral particles with AT-2 are indicated with closed and open arrowheads. Clustered sites that show a strong increase in reactivity with
AT-2 treatment (and report specific nucleocapsid binding sites) are emphasized in cyan; proposed primary and secondary sites are identified with
double (**) and single asterisks (*), respectively. Sites showing a strong reduction in SHAPE reactivity (and reporting the structure destabilizing activity
of nucleocapsid) are emphasized with solid and dashed gray arrows. The bound tRNA(lys3) is shown starting at nucleotide 33. The pseudoknot
involving positions 75–84/443–449 [14] was not predicted directly by our algorithm, but by inference because both loop regions were unreactive
towards SHAPE chemistry.
(B) The 59 regulatory domain is more highly structured than the 39 coding region. Median SHAPE reactivities (solid lines) were calculated over rolling
windows of 45 and 135 nts. Median reactivities for the entire 59 regulatory and 39 coding regions (dashed lines) are 0.13 and 0.40, respectively.
(C) Box plot analysis [64] of distinct reactivity distributions for the 59 and 39 domains. Boxes outline middle 50% of each dataset; medians are shown
with heavy lines. Open circles indicate values .1.5 times the interquartile range (boxed) and are considered outliers. The fences (small horizontal lines
above and below the box) are the largest or smallest non-outlier values.
doi:10.1371/journal.pbio.0060096.g004
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Structures of the HIV-1 Genomein template switching between two RNA monomers during
reverse transcription that leads to recombination [39–41], a
major source of genetic variation for retroviruses. Dimeriza-
tion is a complex process that may involve multiple stem-
loops in the genome, but no single motif has been shown to
be absolutely necessary for dimerization.
In order to assess the dimeric nature of our in vitro
transcript, we resolved monomeric and dimeric conforma-
tions of this RNA in nondenaturing gels (Figure 5A). When
the gel does not contain MgCl2, the HIV transcript RNA has a
mobility identical to a monomer marker. In contrast, when
Mg
2þ is added to the gel and running buffer, the transcript
runs as a well-deﬁned species consistent with formation of a
dimer. This is exactly the behavior expected if the in vitro
transcript forms one or more Mg
2þ-dependent loop-loop
interactions. A similar loop-loop dimer state has been
identiﬁed for the Moloney murine sarcoma retrovirus [33,42].
Dimerization is thought to involve an initial loop-loop
interaction [43] at the self-complementary sequence
G
257CGCGC
262. We ﬁnd that these nucleotides are unreactive
in both the in vitro transcript and ex virio states (boxed
nucleotides, Figure 4A).Thus, both SHAPEreactivities andthe
Mg
2þ-dependent behavior of the in vitro transcript strongly
support formation of intermolecular base pairs at this loop.
In contrast, the genomic RNA obtained from HIV viral
particles forms a dimer that is stable even when subjected to
gel electrophoresis in the absence of Mg
2þ [37]. We therefore
sought to identify the structural differences that distinguish
the loop-loop dimer formed by the in vitro transcript and the
stable dimer in the ex virio state. However, we were unable to
detect any statistically signiﬁcant reactivity differences
between the in vitro transcript and ex virio RNAs, including
in sequences ﬂanking the 257–262 loop (compare red and
black traces in Figures 3B and 5B) or in base-paired regions of
the TAR stem.
Nucleotide resolution SHAPE data are therefore incon-
sistent with models derived from in vitro experiments that
postulate [40,43] that dimerization in mature viruses is
mediated by the formation of stable intermolecular duplexes
involving the stem sequences adjacent to the DIS and TAR
loops. However, our analysis based on HIV-1 genomic RNA
puriﬁed from virions is consistent with recent in vivo
experiments that show neither the TAR stem [44] nor the
ability to form intermolecular base pairs in the DIS stem [45]
are required for viral replication. Instead, we suggest that
HIV-1 genome dimerization is mediated by loop-loop
interactions alone, potentially augmented by interactions
that have not yet been identiﬁed. Another possibility is that
Figure 5. RNA Conformational Changes That Differentiate Ex Virio and In Vitro Transcript States
(A) The in vitro transcript forms a loop-loop dimer. Identical samples of the transcript RNA were resolved in nondenaturing gels, either omitting or
containing 7 mM MgCl2. Markers for monomeric (M) and dimeric (D) conformations are shown.
(B) SHAPE reactivity as a function of nucleotide position for ex virio (red) and transcript (black) RNAs. Difference plot in lower panel has been smoothed
over a 5-nt window.
(C) Secondary structure model for the primer binding site in the absence of tRNA(lys3).
doi:10.1371/journal.pbio.0060096.g005
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Structures of the HIV-1 Genomelarge-scale structural changes occur, but yield almost identi-
cal local nucleotide ﬂexibilities in the pre- and post-dimer
RNAs. We think this is a remote possibility, given the ability
of hSHAPE to detect small changes in local RNA structure
(Figure S1).
Finally, within the predominant state for this large region of
the HIV-1 genome, there are numerous regions that are
persistently accessible to SHAPE chemistry. These regions are
expected to hybridize readily with complementary sequences,
including antisense and RNA interference (RNAi)-based
oligomers, and represent multiple new and attractive targets
foranti-HIVtherapeutics(redandorangepositions,Figure4A).
The tRNA(lys3) Binding Site
Reactivity proﬁles for the four states analyzed in this work
do show limited structural differences, which are consistent
with important, but local, RNA conformation and protein
binding effects. Because hSHAPE gives quantitative informa-
tion at each nucleotide position, structural differences are
readily detected both by comparing two reactivity proﬁles or
by subtracting one proﬁle from another to yield a difference
plot (for example, see lower panel in Figure 5B).
Over the 900 nts of analyzed sequence, there is a single
region that shows signiﬁcant differences between the ex virio
reference state and the transcript RNA, refolded in vitro. This
region lies between nucleotides 160 and 200 (Figure 5B). The
most dramatic difference is that the ex virio state is much less
reactive at positions 182 to 199 (Figure 5B). This region maps
exactly to the main tRNA(lys3) primer binding site [1] and
indicates that the primer is tightly paired to the HIV-1 RNA
genome in viral particles. The in vitro transcript, which is not
bound by tRNA, folds into a different local structure in these
regions (compare the tRNA(lys3) binding sites in Figures 4A
and 5C). We conﬁrmed that these structural differences
reﬂect tRNA binding by dissociating the tRNA from the
genomic RNA via a heating step (Figure S1).
The tRNA primer also has the ability to form additional
interactionswiththegenomicRNA,althoughcurrentproposals
for these interactions diverge widely [16,46,47]. The SHAPE
data show a clear pattern in which the ex virio state is more
reactive at positions 161–166 and less reactive at positions 168–
170, as compared with the in vitro transcript. These reactivity
changes are consistent with tRNA(lys3)-induced structural
rearrangement in RNA sequences outside the primary 18-bp
tRNAprimerbindingsite.TheSHAPEreactivitiesthus strongly
support a model in which the cellular tRNA(lys3) molecule
interacts with the HIV-1 genome via three distinct base-pairing
interactions (Figure 4A, see tRNA(lys3) label).
Direct Analysis of Nucleocapsid Protein–RNA Genome
Interactions
We analyzed the structure of HIV-1 genomic RNA inside
native virions by treating intact viral particles with NMIA and
then extracting and processing the modiﬁed RNA (the in
virio state; see scheme in Figure 6A). Over large regions of the
HIV-1 genome, SHAPE reactivity patterns for the in virio and
protein-free ex virio states are very similar. These data
emphasize that NMIA readily penetrates the viral membrane
and yields quantitative information about HIV RNA structure
in the context of the complex virion environment. We also
observe reproducible local differences between the ex virio
and in virio states that typically span 4–6 nts (compare red
and green proﬁles, Figure 7A). These differences could reﬂect
either different local RNA conformations, like those identi-
ﬁed in the tRNA binding region (Figures 4A and 5C), or the
effects of binding by viral proteins.
The most prominent protein ligand for genomic RNA in
mature HIV virions is the nucleocapsid protein [3,6]. The
nucleocapsid protein functions in two, almost diametrically
opposed, ways. As part of the Gag precursor, the nucleocapsid
domain binds speciﬁcally to the HIV genome to direct
packaging of this RNA into nascent virions. As the mature
nucleocapsid, this protein is thought to interact nonspeciﬁ-
cally with RNA and thereby destabilize RNA duplexes and
facilitate strand rearrangement and annealing events.
These activities are mediated, in part, by two copies of a
CX2CX4HX4C motif that coordinate a zinc ion to form a
compact ‘‘zinc knuckle’’ domain (Figure 6C). This domain has
been shown to bind guanosine in model systems [7]. Thus far,
it had not been possible to convincingly identify speciﬁc sites
in the genome that bind or are destabilized by nucleocapsid
or Gag proteins in virions.
In this work, we took advantage of the prior discovery that
‘‘zinc ejecting’’ agents like 2,29-dithioldipyridine (or Aldri-
thiol-2 [AT-2]; Figure 6B) covalently modify cysteine residues
in the zinc knuckle motifs and disrupt interactions between
the zinc ion and its cysteine ligands. Treatment of viral
particles with AT-2 promotes formation of reagent-nucleo-
capsid and nucleocapsid–nucleocapsid crosslinking and efﬁ-
ciently compromises nucleocapsid–RNA interactions [48–50].
AT-2–treated virions retain the ability to bind to target cells
and to undergo membrane fusion as well as native viral
particles; however, these virions are not infectious and cannot
undergo the ﬁrst steps of reverse transcription [49,50]. Thus,
treatment with AT-2 severely compromises the RNA-binding
activity of the nucleocapsid protein, but leaves the surface of
the virus particle intact [49,50]. To detect nucleocapsid–RNA
interactions inside intact viral particles, we therefore treated
virions with AT-2 and then analyzed the structure of the
resulting genomic RNA using hSHAPE (see scheme, Figure
6B). This approach constitutes a ‘‘reverse footprinting’’
experiment in which the effects of nucleocapsid–RNA
Figure 6. Analysis of the Effects of Nucleocapsid Binding on HIV-1 RNA
Genome Structure by In Situ Disruption Using the Zinc-Ejecting Agent
AT-2
(A and B) Schemes for analyzing HIV-1 genomic RNA structure in virio (A)
and following zinc-ejection with AT-2 (B).
(C) Amino acid sequence and an RNA-bound conformation [58] of the
HIV-1 nucleocapsid protein. Nucleocapsid is gray, and the RNA strand is
green. Bound Zn
2þ is cyan; zinc ligands are yellow and blue. Conserved
stacking interactions for the C-terminal zinc knuckle are shown by space-
filling atoms; hydrogen bonds are shown as small spheres.
doi:10.1371/journal.pbio.0060096.g006
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interactions inside virions.
Nucleocapsid and HIV-1 Genome Structure
Three initial conclusions are apparent from comparison of
the in virio with the ex virio and AT-2-treated states. First,
regions showing strong changes in SHAPE reactivity in the
AT-2-treated state almost always resemble the protein-free ex
virio state (compare blue and red traces, Figures 7A and 8A).
These experiments conﬁrm that AT-2 treatment does disrupt
nucleocapsid–RNA interactions inside virions, but impor-
tantly, that compromising the zinc knuckle structures in the
nucleocapsid protein does not cause formation of nonspeciﬁc
aggregating interactions with the genomic RNA.
Second, disrupting nucleocapsid–RNA interactions by AT-
2 treatment both increases (Figure 7) and decreases (Figure 8)
local nucleotide ﬂexibility in distinct genome regions. The
strongest and most densely arrayed effects of AT-2 treatment
lie in the 59 regulatory domain (upward and downward
pointing arrowheads, respectively; Figure 4A). Thus, even in
the context of an intact HIV-1 genome, nucleocapsid proteins
recognize smaller motifs within this large RNA.
Third, we observe three different interaction motifs
between nucleocapsid protein and the HIV-1 genome. In
order to systematically locate and characterize these motifs,
we subtract the SHAPE reactivities of the in virio state from
the AT-2–treated state, and plot the smoothed differences
(Figures 7B and 8B). These difference plots reveal locations in
the RNA that are reproducibly affected by nucleocapsid
protein binding.
Eleven sites show statistically signiﬁcant (p , 0.001)
increases in SHAPE reactivity in the AT-2–treated state.
Seven of these lie in a single compact domain involving
positions 224–334 in the genome (cyan, Figure 4A). The
strongest single effect of compromising nucleocapsid–RNA
interactions occurs at positions 271–274, followed closely by
positions 239–244 (emphasized with double asterisks and
upwards pointing arrowheads in Figures 4A and 7B). These
sites, which have not been previously implicated in nucleo-
capsid or Gag recognition, are likely to be the primary
interaction motifs for the viral nucleocapsid protein domain
at the 59 end of the HIV-1 genome. We also identify other
sites with smaller AT-2–induced reactivity changes, which we
characterize as secondary (single asterisks; positions 224–227
and 308–312, Figure 4A) and tertiary sites (positions 289–292,
318–320, and 326–329). All seven sites feature a general
structural consensus characterized by a G-rich single-
stranded sequence ﬂanked by stable helices.
The remaining four sites that are not clustered in the
nucleocapsid interaction domain also occur at G-rich single-
stranded regions adjacent to a stable helix (positions 201–205,
381–398, 553–558, and 606–609). In sum, these experiments
indicate that hSHAPE directly identiﬁes RNA interaction
motifs inside native virions, that nucleocapsid protein binds
at speciﬁc sites, and that many nucleocapsid-binding motifs
are clustered in a domain within the 59 regulatory region of
the HIV-1 genome.
Structure Destabilizing Activity of Nucleocapsid
In addition to recognizing speciﬁc motifs in the HIV-1
genome, the nucleocapsid protein also functions to destabi-
lize short RNA helices [6,7]. If the nucleocapsid protein were
Figure 7. A Specific Nucleocapsid Binding Domain in the HIV-1 Genome
(A) SHAPE reactivities as a function of nucleotide position for ex virio (red), in virio (green), and AT-2-treated (blue) states.
(B) Difference plot illustrating the effect of AT-2 treatment on SHAPE reactivity relative to in virio genomic RNA. Sites of enhanced SHAPE reactivity upon
compromising nucleocapsid zinc knuckle structures by AT-2 treatment are reported as positive peaks. Individual nucleotides showing large changes in
reactivity are indicated with upward-pointing arrowheads and correspond to the same symbols shown in Figure 4A. Primary and secondary sites are
emphasized with double (**) and single asterisks (*) , respectively. Reactivity differences are smoothed over a 5-nt window.
doi:10.1371/journal.pbio.0060096.g007
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mising the activity of nucleocapsid (by AT-2 treatment) would
reduce local nucleotide ﬂexibility, and thus decrease SHAPE
reactivities, at deﬁned sites.
Nucleocapsid-mediated destabilization of HIV RNA ge-
nome structure is thus reported as negative peaks in a
difference analysis (Figure 8B). Comparison of SHAPE
reactivities for the in virio state with those for the AT-2
state in a difference analysis indicates that there are two
statistically signiﬁcant (p , 0.001) classes of sites in which
local RNA structure is destabilized by intact nucleocapsid
protein. A series of very strong effects is seen over the ﬁrst
185 nts of the genomic RNA (emphasized with solid gray
arrows, Figures 4A and 8B). No other region in the ﬁrst 900
nts of the HIV-1 genome shows this concentrated and large-
magnitude structural destabilizing activity by nucleocapsid.
We also observe additional sites that lie at relatively widely
spaced intervals in the coding region that experience
enhanced SHAPE reactivity upon compromising the zinc
knuckle motif (dashed gray arrows, Figure 4A). Thus, these
experiments emphasize the unanticipated result that the
helix-destabilizing activity of the nucleocapsid protein does
not fall randomly throughout the genomic RNA, but instead,
has its greatest effect in a compact domain immediately 59 to
the tRNA binding site.
Discussion
A Structure for the HIV-1 Genome
The ﬁrst 10% of the HIV-1 RNA genome represents a
microcosm of many possible classes of interactions that occur
in any large cellular RNA. This RNA contains an extensive
noncoding regulatory domain and also serves as a template
for protein synthesis. The RNA also contains large-scale
structures that are important for forming a dimeric state that
facilitates genetic recombination, for base pairing with a
speciﬁc cellular tRNA, and for binding of the viral Gag
protein or nucleocapsid domain. A complete understanding
of HIV RNA genome structure holds promise for identifying
new targets for anti-HIV interventions.
AcriticalattributeofhSHAPEanalysisisthatitisbothmore
complete and quantitative than conventional approaches.
This difference is readily seen by comparing the single-
nucleotide resolution SHAPE information with prior analyses
of HIV genome structure (Figure 9). It is clear that all of these
studies are mapping nearly identical RNA conformations.
Nucleotides reported to be reactive towards single-strand
selective enzymatic [15] or chemical [8,16] reagents almost
always have high SHAPE reactivities; whereas, nucleotides that
are cleaved by V1 nuclease, which shows a preference for
double-stranded RNA, exhibit low SHAPE reactivity.
Our secondary structure model is most similar to the
proposal of Damgaard et al. [15], but still contains many
substantive differences with respect to this and other models
that reﬂect three innovations unique to the hSHAPE
approach. First, hSHAPE yielded structural information for
94% of all nucleotides in the analyzed region, which is far
more than any prior effort. Near completeness is essential
because RNA secondary structure prediction in the absence
of constraining reactivity data yields structures with signiﬁ-
cant errors, especially as RNA length increases [51–53]. In the
Figure 8. Nucleocapsid Increases SHAPE Reactivity and, by Inference, RNA Flexibility at Multiple Sites 59 to the tRNA(lys3) Primer Binding Site
(A) Absolute SHAPE reactivities for the ex virio (red), in virio (green) and AT-2 treated (blue) states.
(B) Difference plot reporting the effect of AT-2 treatment on the in virio state. Position of bound 39 end of the tRNA primer is shown with a black arrow;
large gray arrow and downward-pointing arrowheads indicate sites of structure destabilization by nucleocapsid.
doi:10.1371/journal.pbio.0060096.g008
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obtained for positions 110–145, 220–243, 276–282, 370–450,
and 465–530, and no data were available 39 of position 720.
Second, our model reduces the inﬂuence of end-effect
artifacts that occur with analysis of small RNA fragments
because it is generated via hSHAPE using full-length genomic
RNA. For example, structures that involve or lie inside of
long-range interactions, such as the 108–114/335–341 stem
(called the U5-AUG interaction [15]) are mispredicted if the
RNA sequence does not include the complete domain. Third,
incorporation of SHAPE reactivity information as a pseudo-
free energy change term makes the structure prediction
calculation relatively insensitive to errors in any single
reactivity measurement.
hSHAPE analysis of four biologically relevant states of the
HIV-1 genome indicates that this RNA has a single, strongly
conserved structure. This result challenges previous pro-
posals for multiple conformations in this region of the
genome [13,40,43] and likely reﬂects that we maintained the
native conformation of authentic, long HIV-1 RNAs. Addi-
tional conformations may exist at other stages of the viral
infectivity cycle.
hSHAPE analysis also indicates that regulatory and protein
coding regions in HIV-1 are structurally distinct as judged by
their quantitative SHAPE reactivities. Regulatory domains are
more highly structured than coding sequences (Figure 4B and
4C).hSHAPEmaybeabroadlyusefultoolforidentifyinghighly
structured regulatory motifs in other viral and cellular RNAs.
Three Classes of Sites at Which Nucleocapsid Modulates
HIV Genome Structure
Understanding the RNA binding speciﬁcity and functions
of the HIV nucleocapsid protein has proven to be challenging
both because nucleocapsid has opposing speciﬁc and non-
speciﬁc binding activities and also because preferred RNA
binding sites had not been clearly deﬁned. In addition,
previous in vitro mapping experiments using dimethyl sulfate
failed to identify any HIV RNA–protein interactions [16],
likely because the limited structural sensitivity of this reagent.
To overcome these challenges, we invented experiments that
focused on the native RNA binding activity of the nucleo-
capsid protein inside wild-type virions.
We used the zinc ejecting agent AT-2 [50] (Figure 6) to
compromise nucleocapsid–RNA interactions inside virions.
The effects of disrupting nucleocapsid–RNA interactions by
AT-2 treatment are highly speciﬁc because changes in SHAPE
reactivity are always localized to a small set of continuous
nucleotides at each site. Notably, we observe structural
changes consistent with both the speciﬁc RNA binding and
with the duplex destabilizing activities of nucleocapsid.
As judged by (1) conserved sequences and structures and (2)
their location in the genome, we identify three classes of
nucleocapsid protein interactions with the HIV-1 genome.
For all three classes, measured differences between the in
virio and AT-2–treated states were highly statistically
signiﬁcant (p , 0.001), whereas, reactivity differences
between nucleotides outside of these sites were statistically
equivalent. The ﬁrst class is a speciﬁc nucleocapsid binding
site motif, and the other two classes are sites at which
nucleocapsid destabilizes RNA duplex structure.
Class 1: Speciﬁc nucleocapsid binding motif. Between
positions 224 and 328 there are seven sites at which AT-2
treatment strongly increased nucleotide ﬂexibility. Sites 1
through 5 are single-stranded internal loop motifs ﬂanked by
double-stranded regions, whereas the remaining two sites
(called the W and SD elements) form short, stable RNA
hairpins (Figure 10A). These interaction motifs can be
Figure 9. Density of SHAPE Reactivity Information Compared with Analyses of Related HIV-1 Sequences Using Conventional Chemical and Enzymatic
Probes
The histogram illustrates SHAPE reactivity as a function of position for the in vitro transcript RNA. Bars are colored according to whether the nucleotide
is predicted to be paired (blue) or single stranded (orange). The results of nuclease mapping [15] (HXB2 isolate) and chemical mapping studies [8,16]
(top, HXB2; bottom, MAL) are indicated below the SHAPE histogram. All mapping data were aligned with the HIV-1 NL4–3 sequence. This plot shows
the most information-dense genome regions as analyzed by conventional approaches; significantly less information was available 39 of position 360,
and none was available 39 of position 720 in the first 10% of the HIV-1 genome.
doi:10.1371/journal.pbio.0060096.g009
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Structures of the HIV-1 Genomecharacterized both structurally, using SHAPE reactivities, and
also by their aggregate information content.
Sites 1–5 and W within the nucleocapsid interaction
domain share a consensus motif comprised of a purine-rich
ﬂexible region of 3–4 nts adjacent to a helix that usually
terminates in a C-G base pair. Identiﬁcation of this structural
consensus was only possible in the context of the new,
SHAPE-constrained, secondary structure. These sites share
both a limited sequence homology and a characteristic
experimental SHAPE reactivity proﬁle (above the solid line,
Figure 10A). Analysis of the information content in these sites
indicates that the most prominent determinants for speciﬁc
RNA binding are a single-stranded guanosine residue
followed by a 39 double-stranded region. The total informa-
tion content [54,55] of this site is 9.6 bits (Figure 10B). The
single-stranded guanosine is an important feature of the
binding site, consistent with structural and biochemical
analyses of nucleocapsid–RNA interactions [56–59]. However,
this nucleotide represents only one-ﬁfth of the total
information in the site, which emphasizes that the overall
structural context plays an equally important role in deﬁning
a nucleocapsid protein binding site.
The seventh site, the splice-donor (SD) stem-loop, is
homologous in terms of sequence information; however, the
ﬂexible loop does not conform with the reactivity consensus
because the loop nucleotides are unreactive towards SHAPE
(see black nucleotides in the SD site, Figure 10A). NMR
experiments show that nucleocapsid interacts with the W and
SD hairpins in completely different ways, involving protein
interactions at opposite faces of an RNA helix [58,59], which
reinforces the SHAPE analysis that local structure and
nucleocapsid protein binding at these two sites are distinct.
The six sites that conform to both the information content
and the SHAPE structure consensus (above the solid line,
Figure 10A) lie in a single domain in our structure model for
the 59 end of the HIV-1 genome. This nucleocapsid
recognition domain overlaps the packaging signal [3] and
the region that forms a loop-loop interaction in the genomic
RNA dimer (Figures 4A and 5A). Our experiments support a
model in which the 223–334 domain dimer interacts with
multiple nucleocapsid molecules and potentially with the
nucleocapsid motif in Gag proteins. The speciﬁc juxtaposi-
tion of multiple high-afﬁnity nucleocapsid/Gag binding sites
in the dimer would then function as the structural motif that
speciﬁcally directs HIV genomic RNA to be packaged in
nascent HIV virions.
Classes 2 and 3: Nucleocapsid-mediated duplex destabiliza-
tion. We also detect two classes of conserved motifs at which
intact nucleocapsid protein increases local ﬂexibility. In Class
2 sites, nucleocapsid destabilizes RNA structure at six
compact regions between the 59 end of the genome and the
tRNA primer binding site (Figure 8B; and solid gray arrows,
Figure 4A). These sites share both a consensus structure and
signiﬁcant sequence similarities (Figure 11A). The Class 2
motif consists of an A/U-rich single-stranded element
followed by a duplex region initiated by a G-C base pair
(with the G usually on ‘‘top’’; Figure 11B). For all sites except
the one containing position 107, the largest differences in
SHAPE reactivity are asymmetrically distributed across the
consensus motif. Nucleocapsid increases local nucleotide
Figure 10. Nucleocapsid Binding Sites in the 59 Regulatory Domain and Their Sequence and Structural Consensus
Sites shown all exhibit statistically significant (p , 0.001) increases in SHAPE reactivity upon compromising RNA-nucleocapsid interactions by AT-2
treatment.
(A) Alignment of internal loop (sites 1–5) and stem-loop (W and SD) nucleocapsid binding sites (from Figure 4A). Nucleotides are colored by their SHAPE
reactivity: red and orange indicate highly reactive positions; black nucleotides are unreactive. Primary and secondary sites are emphasized with double
(**) and single (*) asterisks. N indicates the number of intervening nucleotides on the lower strand.
(B) Information content for sites 1–5. Duplex regions are identified by black bars. Height of each letter indicates information. M represents mutual
information from base pairing [54,55]; each nucleotide is color coded by base identity. For clarity, only the top strand is shown.
doi:10.1371/journal.pbio.0060096.g010
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Structures of the HIV-1 Genomeﬂexibility in the single-stranded region and at 1–2 nts in the
‘‘top’’ duplex strand (compare Figures 11A and 4A).
The six sites in the 39 coding region, termed Class 3 sites,
conform to a different consensus in which nucleocapsid
protein destabilizes RNA structure (dashed arrows, Figure
4A). These six sites can also be characterized by their SHAPE
reactivities and by the net information content of their
sequences. Strikingly, these motifs share a consensus that is
different from the duplex destabilized sites in the 59
regulatory domain (Figure 11C). The motif contains a 59
duplex that terminates in a G-C or other G-containing base
pair followed by an A/U-rich single-stranded region (Figure
11D). For Class 3 motifs, AT-2–mediated reductions in
SHAPE reactivities generally span the ‘‘top’’ strand of the
duplex and then extend in a 39 direction into the single-
stranded region.
Class 2 and 3 sites share important features: both include
single-stranded A/U-rich motifs adjacent to a duplex in which
the ﬁrst base pair includes a guanosine nucleotide. We
propose that the duplex destabilizing activity of the nucle-
ocapsid protein reﬂects protein binding to these guanosine
residues and binding-induced destabilization of the rest of
these short duplexes. The motifs differ in that the single-
stranded elements lie 59 versus 39 of the duplex. We
hypothesize that this asymmetry is linked to the function of
nucleocapsid in facilitating distinct steps in the retroviral
replication cycle. Class 2 sites all lie immediately 59 to the
tRNA(lys3) binding site and therefore represent the ﬁrst
nucleotides traversed by the viral reverse transcriptase during
viral DNA synthesis (solid gray arrows, Figure 4A). These data
are consistent with a model in which nucleocapsid facilitates
the initiation of reverse transcription of the viral genome. In
contrast, nucleocapsid interactions at Class 3 sites may have
evolved to promote a different process involving HIV RNA,
like facilitating translation of the 39 coding sequences and
movement of the ribosome during translation.
Perspective
Using hSHAPE technology, we measured structure at 94% of
the ﬁrst 900 nts of the HIV-1 genome under seven sets of
instructive conditions for a total analysis of 9,100 nts.
Comparing structural information from these states indicates
that large regions of the HIV-1 genome form a single structure,
that regulatory motifs in the genome are highly base paired,
that speciﬁc and nonspeciﬁc RNA binding modes of the
nucleocapsid protein are manifest via interactions with
domain-like elements of the RNA, and that the duplex
destabilizingactivityofnucleocapsidismediatedbytwodistinct
classes of RNA sites. Because of its completeness, hSHAPE
analysis provides information sufﬁcient to discriminate be-
tween otherwise contradictory models for the HIV-1 genome.
Just as DNA sequencing has revolutionized our under-
standing of DNA genome function, high-throughput RNA
structure analysis makes possible investigation of intact RNAs
from any viral or cellular transcriptome, as a function of
multiple biological states. We anticipate that hSHAPE will
contribute signiﬁcantly to establishing the connections
between RNA structure and translational regulation, alter-
native splicing, binding by small interfering and related small
RNAs, higher-order folding and packaging in viruses, and
many other RNA-based processes.
Materials and Methods
HIV-1 particle production. VSV-G pseudotyped HIV-1 NL4–3 viral
particles were produced by cotransfecting the pNL4–3 and pHCMV-
G (VSV-G protein expression construct) [60] plasmids at a ratio of 3:1
into 293T cells as described [61], except that TransIT293 (Mirus Bio)
was used as the transfection agent. In sum, 40 3 150-cm
2 culture
ﬂasks, seeded at a density of 3310
6 293T cells, were transfected with
plasmids 72 h later. Cultures were then incubated for 48 h and
supernatants harvested, clariﬁed by centrifugation at 5,000 g for 10
min, ﬁltered through a 0.2-lm membrane, and stored at 4 8C
overnight. Cultures were incubated for an additional 24 h with fresh
culture medium, and virus-containing supernatant was again col-
lected using the same procedure. Supernatants from both harvests
were pooled and incubated at 4 8C in preparation for treatment with
the AT-2 and NMIA reagents. Viral genomes were quantiﬁed by real-
time reverse-transcription PCR (RT-PCR) [61]; the yield is typically 20
pmol HIV-1 RNA genomes/l cell culture.
HIV-1 particle treatment with AT-2. Aldrithiol-2 (AT-2, systematic
name 2,29-dithiodipyridine; 0.5 M in DMSO, 2.0 ml) or DMSO (2.0 ml)
was added to 1.0 l of virus-containing supernatant and incubated
overnight at 4 8C. Virus particles from the (þ) and ( )A T - 2
experiments were pelleted separately by centrifugation (110,000 g,4
8C, 1.5 h) through a 20% (w/v) sucrose cushion in phosphate buffered
saline. Pellets from 0.5 l of culture ﬂuid were resuspended in 1.0 ml of
NMIA reaction buffer (50 mM Hepes [pH 8], 200 mM NaCl, 0.1 mM
EDTA, and 10% fetal bovine serum).
NMIA modiﬁcation of viral particles. Concentrated samples of
either puriﬁed viral particles or particles treated with AT-2 (500 ll) in
Figure 11. Alignment and Information Content at Sites where AT-2
Treatment Decreases SHAPE Reactivity
(A) Alignment and (B) information content of the six Class 2 sites in the 59
regulatory domain (gray arrow as in Figure 4A). Symbols are described in
Figure 10.
(C) Alignment and (D) information content of six Class 3 sites in the 39
coding region (dashed arrow as in Figure 4A).
doi:10.1371/journal.pbio.0060096.g011
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DMSO) or neat DMSO (50 ll) for 50 min at 37 8C. The virus particle
production, AT-2 treatment, and NMIA modiﬁcation steps were
always performed as a single continuous process and without
intermediate storage steps.
Extraction of HIV-1 genomes from NMIA-modiﬁed particles. RNA
genomes subjected to reaction with NMIA in virio were gently
extracted from viral particles as described [37]. In sum, concentrated
samples of virus particles (in 550 ll of NMIA reaction buffer) were
incubated at 22 8C with 5 ll of proteinase K (20 mg/ml), 33.5 llo f1M
Tris-HCl (pH 7.5), 13.4 ll of 5 M NaCl, 1.34 ll of 0.5 M EDTA, 6.7 llo f
1 M DTT, and 4 ll of glycogen (20 mg/ml) for 30 min. RNA was
puriﬁed by three consecutive extractions with phenol:chloroform:iso-
amyl alcohol (25:24:1), followed by precipitation with ethanol.
Samples were resuspended in 1/23 TE to a concentration of 0.5 lM,
based on quantitative RT-PCR analysis.
Extraction and SHAPE analysis of HIV-1 genomes from native
particles. For the ex virio state, pelleted viral particles were dissolved
in 1 ml of 50 mM Hepes (pH 8.0), 0.5 mM EDTA, 200 mM NaCl, 1%
(w/v) SDS, and 100 lg/ml proteinase K and digested for 30 min at 22
8C. The RNA was then extracted against phenol-chloroform, and the
resulting deproteinized genomes were then aliquoted (2 pmol) and
ﬂash frozen at  80 8C. For SHAPE analysis, the ex virio RNA was
treated with NMIA using the same procedure as for modiﬁcation of
the in vitro RNA (described below), except that the initial 90 8C heat
step was omitted, and the time for incubation in folding buffer was
reduced to 10 min.
RNA transcript. A DNA template encoding the 59 976 nts of the
HIV-1 genome and containing a promoter for T7 RNA polymerase
was generated by PCR (2 ml; 20 mM Tris [pH 8.4], 50 mM KCl, 2.5 mM
MgCl2, 0.5 lM forward [59-TAATA CGACT CACTA TAGGT CTCTC
TGGTT AGACC] and reverse [59-CTATC CCATT CTGCA GCTTC C]
primers, approximately 1 lg of plasmid template containing a partial
sequence of the HIV-1 pNL4–3 molecular clone [obtained from the
National Institutes of Health AIDS Research and Reference Reagent
Program], 200 lM each dNTP, and 25 units Taq polymerase; 34
cycles). The PCR product was recovered by ethanol precipitation and
resuspended in 300 ll of TE (10 mM Tris [pH 8], 1 mM EDTA).
Transcription reactions (3 ml; 37 8C; 5 h; 40 mM Tris [pH 8.0], 5 mM
MgCl2, 10 mM DTT, 4 mM spermidine, 0.01% Triton X-100, 4% [w/v]
PEG 8000, 300 ll of PCR product, and 2 mM each NTP) were initiated
by adding 300 ll of 1 mg/ml T7 RNA polymerase [62]. The RNA
product was precipitated and puriﬁed by denaturing polyacrylamide
gel electrophoresis (5% acrylamide, 13 TBE 7 M urea), excised from
the gel, and recovered by electroelution. The puriﬁed RNA (0.6 nmol)
was resuspended in 100 ll of TE.
Nondenaturing gel electrophoresis of transcript RNA. RNA tran-
script (0.54 pmol, 3 ll, 1/23 TE) was combined with internally [
32P]-
labeled transcript RNA (7 fmol, 1 ll) and denatured by heating at 95
8C for 5 min and placing on ice. Folding buffer (1 llo f5 3; 250 mM
Hepes [pH 8], 1 M potassium acetate [pH 8], 25 mM MgCl2) was
added, and the sample was incubated at 37 8C for 1 h. Dimer markers
were generated by the same procedure, except that 5 pmol of RNA
were used and incubation was at 60 8C; monomer markers were
generating by heating labeled transcript RNA (7 fmol, 5 ll) to 95 8C
for 10 min in 1/23 TE. Gel loading dye (30% glycerol, 13TBE, 7 mM
MgCl2, 0.01% xylene cyanol; 1.67 ll) was added, and all samples were
incubated on ice until resolution by electrophoresis (2 ll of sample
per well, 4% polyacrylamide, 13TBE, 7 W, 2.5 h) either in the absence
or presence of 7 mM MgCl2. If MgCl2 was present during the
separation, it was added to both the running buffer and the gel; the
running buffer was recycled every 10 min to maintain a constant
[Mg
2þ] in the gel.
Modiﬁcation of transcript RNA. RNA (2 pmol) in 14.4 ll of 1/23TE
was refolded by heating at 95 8C, placing on ice, adding 3.6 llo f
folding buffer, and incubating at 37 8C for 60 min. The folded RNA
was divided equally between two tubes and treated with either NMIA
[22,23] (1 ll, 32 mM in DMSO) or neat DMSO (1 ll) and allowed to
react for 60 min at 37 8C. RNA from the (þ) and ( ) NMIA reagent
experiments was recovered by ethanol precipitation and resuspended
in 10 ll of TE.
Detection of 29-O-adducts by primer extension. In vitro transcript
or authentic genomic RNA (1 pmol, 10 ll, in 13TE) corresponding to
either the (þ)o r(  ) NMIA reactions was heated to 95 8C for 3 min and
cooled on ice for 1 min. Fluorescently labeled primer (3 ll) was added
to the (þ) (0.2 lM Cy5) and ( ) (0.4 lM WellRED D3) NMIA reactions,
respectively, and primer-template solutions were incubated at 65 8C
for 5 min and 35 8C for 10 min. Primer extension was initiated by
addition of enzyme mix (6 ll; 250 mM KCl; 167 mM Tris-HCl [pH 8.3];
1.67 mM each dATP, dCTP, dITP, and dTTP; 10 mM MgCl2;5 28C, 1
min) and Superscript III (1 ll, 200 units; Invitrogen). Extension
continued at 52 8C for 15 min. Sequencing reactions used to identify
peaks in the (þ) and ( ) reagent experiments contained transcript
RNA (1 pmol, in 9 ll of TE), 3 ll of primer (2 lM WellRED D2 or 1.2
lM LICOR IR 800), enzyme mix (6 ll), ddNTP solution (1 ll; 0.25 mM
ddGTP and 10 mM other nucleotides), and Superscript III (1 ll). Four
sets of primers were used that were complementary to positions 342–
363 (59-CGCTT AATAC CGACG CTCTC GC), 535–555 (59-CTTCT
GATCC TGTCT GAAGG G), 743–762 (59-CCATT TGCCC CTGGA
GGTT C), or 956–976 (CTATC CCATT CTGCA GCTTC C). Depend-
ing on the quality of synthesis, primers were puriﬁed by denaturing
gel electrophoresis (20% polyacrylamide, 13 TBE, 7 M urea;
dimensions 0.75 cm 3 28.5 cm [w] 3 23 cm [h]; 32W; 90 min) and
passively eluted into 1/23 TE overnight. The four reactions
corresponding to a complete hSHAPE analysis ((þ) NMIA, ( ) NMIA,
and two sequencing reactions) were combined and precipitated with
ethanol in the presence of acetate, EDTA, and glycogen. Pellets were
washed twice with 70% ethanol, dried under vacuum, and resus-
pended in deionized formamide. cDNA samples were separated on a
33-cm 3 75-lm capillary using a Beckman CEQ 2000XL DNA
sequencer.
Data processing. Raw ﬂuorescence intensity versus elution time
proﬁles were analyzed using a draft software suite called Shape-
Finder. ShapeFinder is derived from BaseFinder [25], which is a
modular, extensible software package originally designed for DNA
base calling and sequence analysis, and is currently being reﬁned for
analysis of quantitative hSHAPE reactivity information (S. M. Vasa, N.
Guex, K. A. Wilkinson, K. M. Weeks and M. C. Giddings, unpublished
data). For readers interested in immediate access to this software, a
beta version is available for download at http://rd.plos.org/pbio.
0060096.1. Processing steps included (1) baseline correction, (2) color
separation to correct for spectral overlap of the ﬂuorescent dyes, and
(3) mobility shift correction to align corresponding peaks in the four
channels. Areas under each peak in the (þ) and ( ) NMIA traces were
obtained by (1) peak detection and interpolation to align peaks in
each channel with the RNA sequence and (2) performing a whole-
trace Gaussian-ﬁt integration. Integrated peak intensities were
corrected for signal decay [63] as a function of read length by
assuming a constant probability for extension at each nucleotide
position, after excluding the 2% of most-highly reactive peaks:
D ¼ Apelution time þ C ð1Þ
Where D is the signal decay adjustment factor, A and C are
scaling factors that reﬂect the arbitrary initial and ﬁnal intensities of
the trace, and p is the probability of extension at each nucleotide.
Typical values for p spanned 0.995–0.999 for elution times in units of
2 Hz. Each peak intensity calculated at the same elution time was
divided by D. SHAPE intensities at each individual nucleotide were
examined manually to identify positions where high background was
present in the ( ) reagent control experiment. A very small number of
positions fell into this category (,6%) and were marked as
containing no data. Quantitative SHAPE reactivities for individual
datasets were normalized to a scale in which 0 indicates an unreactive
site and the average intensity at highly reactive sites is set to 1.0. The
normalization factor for each dataset was determined by ﬁrst
excluding the most-reactive 2% of peak intensities and then
calculating the average for the next 8% of peak intensities. All
reactivities were then divided by this average. This simple normal-
ization procedure places all absolute reactivities on a scale of 0 to
approximately 1.5 (ordinate, Figure 2D). Normalized hSHAPE
reactivities from each primer extension reaction were processed
independently. Processed traces were then found to fall on the same
absolute scale, without further adjustment (for example, compare
overlap of closed and open columns, Figure 3A). For each state,
SHAPE information was obtained by combining information from
four overlapping reads of approximately 300 nts each; two to three
independent repetitions were obtained for each read; and standard
deviations were small, on average 0.1 normalized SHAPE unit or less.
Ability of hSHAPE to detect small changes in RNA structure. These
experiments are outlined in Figure S1. PCR templates for the 362-
mer transcript and U
22CU
24-deletion mutants were produced in the
context of a 39 structure cassette [22] using the same reverse cassette
primer (59-GAACC GGACC GAAGC CCGAT TGGTA ACCCG
AAGGT CACTT CCGCT TAATA CTGAC GCTC) and different
forward primers (59-TAATA CGACT CACTA TAGGC CTTCG
GGCCA AGGTC TCTCT GGTTA GACC) and (59-TAATA CGACT
CACTA TAGGC CTTCG GGCCA AGGTC TCTCT GGTTA GACCA
GAGAG CCTGG G), respectively. tRNA(lys3) was dissociated from the
PLoS Biology | www.plosbiology.org April 2008 | Volume 6 | Issue 4 | e96 0896
Structures of the HIV-1 Genomeex virio RNA by heating to 90 8C for 3 min and refolding 10 min in
reaction buffer at 37 8C.
Incorporation of hSHAPE constraints into RNAstructure. SHAPE
intensities were converted into a pseudo-free energy change term in
the RNAstructure program [28] (K. E. Deigan, T. W. Li, D. H.
Mathews, and K. M. Weeks, unpublished data) using:
DGSHAPE ¼ mln½SHAPE reactivity þ 1:0 þb ð2Þ
which is applied to each nucleotide in each stack of two base pairs.
Therefore, the pseudo-free energy is added twice per nucleotide
paired in the interior of a helix and once per nucleotide paired at the
end of a helix. The intercept, b, is the free-energy bonus for
formation of a base pair with zero or low SHAPE reactivity, whereas
m, the slope, drives an increasing penalty for base pairing as the
SHAPE reactivity increases. The b and m parameters were 0.6 and 1.7
kcal/mol, respectively (per nucleotide). The maximum allowed
distance between paired bases was restrained to be 300 nts or less.
Increasing the maximum pairing distance to 600 nts yielded a series
of short, poorly predicted, and transient pairings. The reactivity of
the nucleotides participating in these interactions could be explained
by shorter distance pairings. To determine the pairing persistence,
structures were also computed for larger values of the b and m
parameters, which has the effect of increasing the contribution of the
SHAPE reactivity information on the secondary structure calculation.
Helices considered to be highly predicted persisted even when these
parameters were set to values as high as b ¼ 0 and m . 4.
RNAstructure is available for download at http://rd.plos.org/pbio.
0060096.2.
Statistical analyses, general procedures. To analyze differences in
SHAPE reactivities between groups of nucleotides, such as comparing
the 59 regulatory versus 39 protein coding regions, several tests were
applied to determine the statistical characteristics of the subgroups
and to determine the appropriate statistical measures of differences.
We applied Levene’s test to analyze homoscedasticity, which
conﬁrmed that the SHAPE reactivity variances between analyzed
groups of nucleotides are equivalent. However, quantile-quantile (Q-
Q) plots of these data indicated departures from normality for the
SHAPE reactivity data, so the standard Student t-test could not be
applied. Instead, we applied the Wilcoxon rank sum test to analyze
the statistical SHAPE reactivity differences between groups, which
eliminates dependence on normality by rank-ordering the reactivity
data and deriving statistics from the rankings. In the small number of
cases in which reactivity data were missing for a nucleotide in one
group, then that nucleotide was removed from the other groups in a
given comparison. All analyses were performed using the open source
R package (version 2.6.1) [64].
Differences in structure between regulatory and coding domains. SHAPE
reactivity data for the ex virio state were divided into two groups
corresponding to the 59 regulatory (nucleotides 1–335) and Gag
coding sequences (nucleotides 336–906) and analyzed by the
Wilcoxon rank sum test. Differences between the 59 regulatory and
39 coding regions were highly signiﬁcant (p , 0.0001).
Absence of differences between TAR and DIS SHAPE reactivities for in vitro
transcript, ex virio, and AT-2–treated states. Reactivity data were analyzed
for the TAR (nucleotides 1–57) and DIS (nucleotides 236–282)
regions. Three groups of reactivities were collected, reﬂecting each
RNA state (in vitro, ex virio, and AT-2 treated) with 141 and 129 nts
for the TAR and DIS regions, respectively. We applied a one-way
analysis of variance (ANOVA) to the three groups for each of the
regions, to test whether they displayed statistically signiﬁcant differ-
ences among groups for either region. The F ratio was calculated to
determine whether the means of individual groups, corresponding to
the three states, represent signiﬁcant variation from the overall
mean. The initial F ratio values calculated showed no signiﬁcant
difference between groups, with p-values of 0.63 for TAR and 0.98 for
DIS, respectively. However, because SHAPE reactivities are not
normally distributed, the F ratio can be inaccurate. To assess whether
the initial F ratio was representative of the underlying distribution,
we performed bootstrap resampling of the SHAPE data from the
groups, with replacement [65]. We recalculated the F ratio for each of
15,000 repetitions, then calculated p-values by determining the
number of times F ratios with larger (more extreme) values were
obtained. The bootstrap–re-estimated p-values were 0.625 for TAR
and 0.974 for DIS, in close agreement with the initial calculation. This
indicates that the original F ratio, which showed no statistical
difference between these groups, is representative of the lack of
difference between the TAR and DIS structures in these three HIV-1
RNA genome states.
Statistical signiﬁcance of nucleocapsid binding sites. SHAPE reactivity
data were divided into two groups corresponding to the in virio and
AT-2–treated states. For each state, the nucleotides were divided into
the three nucleocapsid protein binding classes (Figures 7 and 8). This
resulted in two groups of 34, 42, and 28 nts for the Class 1, 2, and 3
sites, respectively. Each of these were compared using the Wilcoxon
rank sum test. For all three classes of nucleocapsid protein
interaction sites, p-values , 0.001, indicating statistically signiﬁcant
differences in the SHAPE reactivity between in virio and AT-2–
treated states. We also performed the inverse analysis, using all
nucleotides that were not associated with any of the three classes of
nucleocapsid sites. The Wilcoxon test yielded a p-value of 0.859,
indicating that nucleotides outside of these sites were statistically
equivalent.
Information content of nucleocapsid protein binding sites was
calculated as described [54,55]. Because the number of sequences was
relatively small, information content shows some variation depending
on the speciﬁc alignment. For example, information content was 9.6
bits for the alignment shown in Figure 10; alternative alignments
yielded information contents of 8 to 12 bits.
Supporting Information
Dataset S1. SHAPE Reactivity Data
This dataset contains the complete SHAPE reactivity data for the ex
virio, in virio, AT-2 treated, and in vitro transcript states.
Found at doi:10.1371/journal.pbio.0060096.sd001 (346 KB XLS).
Figure S1. hSHAPE Accurately Detects Small Changes in HIV-1
Genome Structure
In this ﬁgure, structures are illustrated schematically at the left.
Representative nucleotides are colored by their experimental SHAPE
reactivity using the scale shown in Figure 4. Reactivity histograms are
shown at the right; large upward or downward pointing colored
arrows indicate increases or decreases in SHAPE reactivity, respec-
tively.
(A) Deletion of the U
22CU
24 bulge in TAR. Native and DU
22CU
24
histograms are black and purple, respectively.
(B) SHAPE analysis of the 79–85/443–339 pseudoknot. Pseudoknot
structure was analyzed for the 976 nt in vitro transcript (black
histogram) as compared to a 362 nt RNA that lacks sequences
required to form the pseudoknot (cyan).
(C) Ex virio genomic RNA bound to tRNA(lys) (red) undergoes a local
rearrangement to maximize intra-molecular pairs (orange) upon
heating and refolding.
Found at doi:10.1371/journal.pbio.0060096.sg001 (294 KB PDF).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
ber for the pNL4–3 molecular clone is AF324493.
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